Innate Pharma S.A.
IPHYF
$1.50
$0.139.29%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -51.83% | -55.31% | -28.33% | -34.49% | -18.17% |
| Total Receivables | 425.35% | 387.31% | -90.46% | -91.28% | -96.69% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -4.01% | -10.95% | -21.65% | -28.38% | -53.60% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 435.14% | 396.44% | -40.84% | -45.93% | -85.87% |
| Total Current Assets | -38.22% | -42.69% | -36.18% | -41.67% | -45.74% |
|
|
|||||
| Total Current Assets | -38.22% | -42.69% | -36.18% | -41.67% | -45.74% |
| Net Property, Plant & Equipment | -3.76% | -10.73% | -5.52% | -13.64% | -23.95% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -86.28% | -87.27% | -41.63% | -46.65% | -12.82% |
| Total Assets | -35.95% | -40.59% | -32.76% | -38.54% | -40.62% |
|
|
|||||
| Total Accounts Payable | 7.00% | -0.75% | -43.00% | -47.90% | -13.32% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 14.62% | 6.32% | 9.67% | 0.24% | -8.71% |
| Total Finance Division Other Current Liabilities | 41.31% | 31.08% | -14.95% | -22.26% | -30.83% |
| Total Other Current Liabilities | 41.31% | 31.08% | -14.95% | -22.26% | -30.83% |
| Total Current Liabilities | 26.02% | 16.89% | -15.62% | -22.88% | -22.06% |
|
|
|||||
| Total Current Liabilities | 26.02% | 16.89% | -15.62% | -22.88% | -22.06% |
| Long-Term Debt | -30.09% | -35.15% | -25.53% | -31.93% | -32.12% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 5.76% | -1.90% | 0.91% | -7.74% | -72.16% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -17.88% | -23.82% | -23.77% | -30.32% | -16.53% |
| Total Liabilities | -6.34% | -13.12% | -21.58% | -28.32% | -22.34% |
|
|
|||||
| Common Stock & APIC | 18.44% | 9.87% | 15.66% | 5.72% | -4.68% |
| Retained Earnings | -27.84% | -18.59% | -23.56% | -12.94% | -7.42% |
| Treasury Stock & Other | 4,588.21% | 4,257.81% | 268.61% | 236.95% | -94.88% |
| Total Common Equity | -378.63% | -358.46% | -80.42% | -82.10% | -84.06% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -378.63% | -358.46% | -80.42% | -82.10% | -84.06% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -378.63% | -358.46% | -80.42% | -82.10% | -84.06% |
|
|
|||||